LLS is the world's largest voluntary health agency dedicated to finding cures for leukemia, lymphoma, myeloma and other blood cancers. Thanks to research, survival rates for patients with many blood cancers have doubled, tripled and even quadrupled since the early 1960s. Despite these advances, about one third of patients with a blood cancer still do not survive even five years after their diagnosis, which is why more funding is needed to bring better therapies to patients, and faster.
Provide resources to fund lifesaving research and services for patients and their families.
To date, LLS has invested more than $ 1 billion in research to advance therapies and save lives. LLS research grants have funded many of today's most promising advances, including targeted therapies and immunotherapies. Sustained research investments are fueling an explosion of innovative science and clinical successes. New safe and effective treatments, once unimaginable, are saving lives today.